神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2016 中国视神经脊髓炎谱系疾病诊断与治疗指南

2016-05-18 中国免疫学会神经免疫分会 中国神经免疫学和神经病学杂志.2016,23(5):155-166.

视神经脊髓炎谱系疾病

NMO临床上多以严重的视神经炎(optic neuritis，ON)和纵向延伸的长节段横贯性脊髓炎(longitudinally extensive transverse myelitis，LETM)为特征表现，常于青壮年起病，女性居多，复发率及致残率高｡

中文标题：

2016 中国视神经脊髓炎谱系疾病诊断与治疗指南

发布机构：

中国免疫学会神经免疫分会

发布日期：

2016-05-18

简要介绍：

视神经脊髓炎(neuromyelitis optica，NMO)是一种免疫介导的以视神经和脊髓受累为主的中枢神经系统(CNS)炎性脱髓鞘疾病｡NMO的病因主要与水通道蛋白4抗体(AQP4-IgG)相关，是不同于多发性硬化(multiple sclerosis，MS)的独立疾病实体｡


NMO临床上多以严重的视神经炎(optic neuritis，ON)和纵向延伸的长节段横贯性脊髓炎(longitudinally extensive transverse myelitis，LETM)为特征表现，常于青壮年起病，女性居多，复发率及致残率高｡

制定者：
中国免疫学会神经免疫学分会
中华医学会神经病学分会神经免疫学组

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 中国视神经脊髓炎谱系疾病诊断与治疗指南)] GetToolGuiderByIdResponse(projectId=1, id=e46da1c001292a7f, title=2016 中国视神经脊髓炎谱系疾病诊断与治疗指南, enTitle=, guiderFrom=中国神经免疫学和神经病学杂志.2016,23(5):155-166., authorId=null, author=, summary=NMO临床上多以严重的视神经炎(optic neuritis，ON)和纵向延伸的长节段横贯性脊髓炎(longitudinally extensive transverse myelitis，LETM)为特征表现，常于青壮年起病，女性居多，复发率及致残率高｡, cover=, journalId=null, articlesId=null, associationId=152, associationName=中国免疫学会神经免疫分会, associationIntro=null, copyright=0, guiderPublishedTime=Wed May 18 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=视神经脊髓炎(neuromyelitis optica，NMO)是一种免疫介导的以视神经和脊髓受累为主的中枢神经系统(CNS)炎性脱髓鞘疾病｡NMO的病因主要与水通道蛋白4抗体(AQP4-IgG)相关，是不同于多发性硬化(multiple sclerosis，MS)的独立疾病实体｡ <div><br> NMO临床上多以严重的视神经炎(optic neuritis，ON)和纵向延伸的长节段横贯性脊髓炎(longitudinally extensive transverse myelitis，LETM)为特征表现，常于青壮年起病，女性居多，复发率及致残率高｡<br> <br> <div><span style="font-weight: bold;">制定者：</span> <div>中国免疫学会神经免疫学分会</div> <div>中华医学会神经病学分会神经免疫学组</div> <div>中国医师协会神经内科分会神经免疫专业委员会<br><br> 拓展指南：<strong>与<font color=red>视神经脊髓炎</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e46da1c001292a7f" title="2016 中国视神经脊髓炎谱系疾病诊断与治疗指南" target=_blank>2016 中国视神经脊髓炎谱系疾病诊断与治疗指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=94c571c00116399d" title="视神经脊髓炎诊断和治疗中国专家共识" target=_blank>视神经脊髓炎诊断和治疗中国专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=135ef1c0009586cf" title="2013 亚太促进特发性脱髓鞘疾病（多发性硬化和视神经脊髓炎）患者早期治疗指南" target=_blank>2013 亚太促进特发性脱髓鞘疾病（多发性硬化和视神经脊髓炎）患者早期治疗指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7b1cd1c000e78725" title="2010 EFNS视神经脊髓炎诊断和管理指南" target=_blank>2010 EFNS视神经脊髓炎诊断和管理指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A7%86%E7%A5%9E%E7%BB%8F%E8%84%8A%E9%AB%93%E7%82%8E" target=_blank>有关视神经脊髓炎更多指南</a></ul></div></div></div>, tagList=[TagDto(tagId=10517, tagName=视神经脊髓炎谱系疾病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21072, categoryName=梅斯医学-罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10080, appHits=992, showAppHits=29, pcHits=7190, showPcHits=2900, likes=170, shares=40, comments=3, approvalStatus=1, publishedTime=Sun Oct 02 16:19:53 CST 2016, publishedTimeString=2016-05-18, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Sun Oct 02 16:19:53 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 08:01:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 中国视神经脊髓炎谱系疾病诊断与治疗指南)])
2016 中国视神经脊髓炎谱系疾病诊断与治疗指南
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1009796, encodeId=21f11009e96e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJwIA2WteU2Q2fgyjdyxyFxNiauyKGNibfiaRjOCp60DxicJW8iaA24c7ib114W43iaNB3RzCKCnOmw99jNw/132, createdBy=8f232026582, createdName=医学界有为青年, createdTime=Fri Aug 20 19:27:19 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=204127, encodeId=b1e420412e89, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCl4zaE0zq0kFsKQmg3vef7gFticiaFX50TWZibZibNHbk3YSJ5uSh1a0DcUiaVIHkoe2Om3eYg7oUTlf/0, createdBy=442c2063958, createdName=海棠胜雪, createdTime=Mon May 29 22:04:09 CST 2017, time=2017-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156695, encodeId=60a015669567, content=好好学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Nov 18 23:22:04 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2021-08-20 医学界有为青年

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1009796, encodeId=21f11009e96e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJwIA2WteU2Q2fgyjdyxyFxNiauyKGNibfiaRjOCp60DxicJW8iaA24c7ib114W43iaNB3RzCKCnOmw99jNw/132, createdBy=8f232026582, createdName=医学界有为青年, createdTime=Fri Aug 20 19:27:19 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=204127, encodeId=b1e420412e89, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCl4zaE0zq0kFsKQmg3vef7gFticiaFX50TWZibZibNHbk3YSJ5uSh1a0DcUiaVIHkoe2Om3eYg7oUTlf/0, createdBy=442c2063958, createdName=海棠胜雪, createdTime=Mon May 29 22:04:09 CST 2017, time=2017-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156695, encodeId=60a015669567, content=好好学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Nov 18 23:22:04 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2017-05-29 海棠胜雪

    好好学习一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1009796, encodeId=21f11009e96e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJwIA2WteU2Q2fgyjdyxyFxNiauyKGNibfiaRjOCp60DxicJW8iaA24c7ib114W43iaNB3RzCKCnOmw99jNw/132, createdBy=8f232026582, createdName=医学界有为青年, createdTime=Fri Aug 20 19:27:19 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=204127, encodeId=b1e420412e89, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuCl4zaE0zq0kFsKQmg3vef7gFticiaFX50TWZibZibNHbk3YSJ5uSh1a0DcUiaVIHkoe2Om3eYg7oUTlf/0, createdBy=442c2063958, createdName=海棠胜雪, createdTime=Mon May 29 22:04:09 CST 2017, time=2017-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=156695, encodeId=60a015669567, content=好好学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Nov 18 23:22:04 CST 2016, time=2016-11-18, status=1, ipAttribution=)]
    2016-11-18 susice

    好好学习下

    0